Table 2.
Medical variable | Data available, n | All, n = 52 | < 5 yr old, n = 17 | ≥ 5 yr old, n = 35 | P value, |
< 5 yr old vs ≥ 5 yr old | |||||
Failure to thrive, weight-for-age z-score < 2 SD | 52 | 14 (26.9) | 3 (17.6) | 11 (31.4) | 0.29 |
Short stature, height-for-age z-score < 2 SD | 51 | 10 (19.6) | 1 (5.9) | 9 (26.5) | 0.089 |
Medical complications | |||||
Portal hypertension | 52 | 21 (40.4) | 2 (11.8) | 19 (54.3) | 0.034 |
Variceal bleeding | 52 | 13 (25.0) | 1 (5.8) | 12 (34.3) | 0.026 |
Ascites | 52 | 3 (5.8) | 2 (11.8) | 1 (2.9) | 0.20 |
Cholangitis | 52 | 19 (36.3) | 8 (47.1) | 11 (31.4) | 0.27 |
Portopulmonary hypertension | 52 | 2 (3.8) | 0 (0) | 2 (5.7) | 0.31 |
Hepatopulmonary syndrome | 52 | 0 (0) | 0 (0) | 0 (0) | - |
Bone fracture | 52 | 0 (0) | 0 (0) | 0 (0) | - |
Laboratory indices | |||||
White cell count, < 4 × 109/L | 49A | 13 (25.0) | 1 (5.9) | 13 (40.6) | 0.017 |
Platelet count, < 150 × 109/L | 50A | 28 (53.8) | 8 (47.1) | 22 (66.7) | 0.28 |
Total bilirubin, ≥ 17 μmol/L | 52 | 26 (50.0) | 6 (35.3) | 21 (60.0) | 0.09 |
Albumin, < 35 g/L | 52 | 6 (11.5) | 1 (5.8) | 5 (14.3) | 0.37 |
International normalized ratio, ≥ 1.3 | 52 | 12 (23.1) | 5 (29.4) | 7 (20.0) | 0.70 |
Alanine transferase, ≥ 40 IU/L | 52 | 35 (67.3) | 13 (76.5) | 24 (68.6) | 0.56 |
Aspartate transferase, ≥ 40 IU/L | 52 | 38 (73.1) | 15 (88.2) | 25 (71.4) | 0.18 |
Gamma glutamyl-transpeptidase, ≥ 55 IU/L | 52 | 36 (69.2) | 11 (64.7) | 27 (77.1) | 0.34 |
Absence of any medical complications | 52 | 15 (28.8) | 6 (35.3) | 9 (25.7) | 0.98 |
Absence of abnormal laboratory indices | 49 | 3 (6.1) | 1 (5.9) | 2 (6.3) | 0.47 |
Ideal medical outcome | 49 | 1 (2.0) | 0 (0) | 1 (2.9) |
A: Data for white cell count for 3 patients and platelet count for 2 patients were not available for review. Ideal medical outcome was defined as an absence of any medical complications and presence of normal laboratory indices.